> Research Use Only Disclaimer: All products discussed in this article are sold strictly for laboratory research and scientific purposes. They are not approved for human consumption, clinical use, or veterinary application. Always consult applicable regulations before handling research compounds.
UK SARMs is a European-based research compound supplier with 61 active product listings on Peptides.SO. As the name suggests, the company's catalog spans both SARM research compounds and peptides — making it a dual-category supplier that serves researchers working across selective androgen receptor modulator biology, growth hormone secretion research, tissue repair, metabolic science, and longevity compound research.
For European and UK-based researchers, UK SARMs represents one of the more accessible regional suppliers with broad catalog coverage and competitive pricing across compound categories.
Company Overview
UK SARMs occupies a distinctive niche in the research compound market: a European supplier that covers both SARM compounds and peptides under one catalog, rather than specializing in one or the other. This dual-category approach serves researchers who want a single regional supplier relationship across multiple compound families.
The 61-listing catalog on Peptides.SO reflects meaningful investment in compound sourcing — the supplier covers GH secretagogues, peptide blends, melanocortin compounds, GLP-1/metabolic research, longevity peptides, SARMs, and wellness supplements. Regional supply chains for European researchers have historically involved additional cost and lead time through U.S. suppliers; UK SARMs positions itself to solve that problem.
Catalog Depth and Breadth
Growth Hormone Secretagogues
CJC-1295 with DAC ($49.99), CJC-1295 No DAC ($49.99), Ipamorelin/CJC-1295 Blend ($49.99), and GHRP-6 ($49.99) cover the standard pituitary-hypothalamic axis research compound set. The core GH secretagogue coverage is solid for researchers studying GH release biology and IGF-1 secretion.
GLP-1 and Advanced Metabolic Research
The GLP-1 segment is particularly notable: UK SARMs carries Retatrutide ($109.99) — Eli Lilly's triple GLP-1R/GIPR/GCGR agonist in Phase 3 trials (LY3437943) — alongside Mazdutide 10mg ($89.99), and standard GLP-1 compound coverage. This positions UK SARMs as a supplier tracking frontier metabolic research compound demand rather than relying solely on established catalog staples.
Tissue Repair and Regenerative Peptides
BPC-157 ($44.99–$54.99), Thymosin Beta-4 (TB-500) 10mg ($69.99), GHK-Cu/BPC-157/TB-500 Blend ($24.99), and GLOW Peptide ($69.99) provide solid tissue repair and regeneration compound coverage. The multi-compound healing blend at $24.99 represents strong value for researchers running combined tissue repair protocols.
Melanocortin Peptides
Melanotan I 10mg ($39.99), PT-141 ($39.99), Nasal Tanners ($49.99), and the Beauty Blend (GHK-Cu/KPV at $24.99) cover the melanocortin and cosmetic research categories. Multiple tanning peptide format options reflect engagement with this research segment.
Longevity and Specialty Peptides
MOTS-c ($49.99), KPV ($49.99), Oxytocin 10mg ($49.99), NAD+ ($99.00), and IGF-1 LR3 ($45.99) round out the longevity and specialty research compound offerings. The NAD+ listing in particular extends coverage into the cellular energy metabolism and longevity research space.
HGH and Hormone Research
HGH (Human Growth Hormone) at $39.99 — listed for research use — alongside Enclomiphene Citrate ($44.99) covers researchers studying growth hormone biology and hormonal homeostasis.
SARMs and Performance Research
The SARM catalog is extensive: LGD-4033 ($59.99), RAD-140 ($79.98), MK-2866 ($79.98), S-4 Andarine ($79.98), S23 ($79.99), YK-11 ($59.99), RAD-150 ($59.99), SR-9009 Stenabolic ($59.99), SR-9011 REV-ERB ($59.99), GW501516 ($79.98), GW0742 ($49.99), ACP-105, and MK-677 ($79.99) cover effectively the entire standard SARM research landscape. This is among the most complete SARM catalogs of any supplier listed on Peptides.SO.
Wellness and Supplement Compounds
Alpha GPC ($49.99), Ashwagandha ($49.99), Tongkat Ali ($49.99), Turkesterone ($75.99), and On Cycle Support ($49.99) extend the catalog into wellness supplement territory, reflecting a broader research compound portfolio philosophy.
Hair Loss Research
RU58841 ($79.98) is listed for researchers studying androgen receptor antagonism in hair follicle biology.
COA Standards and Testing Quality
UK SARMs provides analytical testing documentation for catalog products. European regulatory context for research compounds differs from U.S. markets; researchers should confirm regional regulatory compliance and testing documentation specifics directly with the supplier for precision applications.
Pricing Analysis
Pricing is competitive across categories, particularly for the SARM segment where UK SARMs often matches or undercuts U.S. competitors.
| Compound | Format | Price |
|---|---|---|
| GHK-Cu/BPC-157/TB-500 Blend | Standard | $24.99 |
| Beauty Blend (GHK-Cu/KPV) | 50mg/20mg | $24.99 |
| Melanotan I | 10mg | $39.99 |
| PT-141 | Standard | $39.99 |
| IGF-1 LR3 | Standard | $45.99 |
| CJC-1295 No DAC | 5mg | $49.99 |
| MOTS-c | Standard | $49.99 |
| LGD-4033 | Standard | $59.99 |
| TB-500 | 10mg | $69.99 |
| Retatrutide | Standard | $109.99 |
Pros and Cons
| Pros | Cons |
|---|---|
| One of the most complete SARM catalogs on Peptides.SO | Location listed as "Unknown" — limited regional transparency |
| Covers both SARMs and peptides under one supplier | No verified badge status on Peptides.SO |
| Frontier metabolic compounds (Retatrutide, Mazdutide) | No published rating/review data yet |
| Competitive blend pricing ($24.99 healing blend) | Premium peptide pricing vs. some U.S. suppliers |
| Wide wellness supplement coverage | — |
Verdict
UK SARMs delivers genuine value as a dual-category research compound supplier. The SARM catalog depth is exceptional — effectively covering the complete standard research SARM library. The peptide coverage is solid across GH axis, tissue repair, melanocortin, and longevity compounds. The presence of frontier metabolic research compounds like Retatrutide and Mazdutide indicates active catalog curation.
For researchers wanting a single supplier relationship covering both SARM and peptide research — particularly those seeking European supply chain access — UK SARMs is a strong 2026 option worth evaluating alongside verified U.S. suppliers on Peptides.SO.
All products are for laboratory research purposes only. Not for human consumption.
---
Frequently Asked Questions: UK SARMs
Q: Does UK SARMs ship to continental Europe, or only to the UK?
A: UK SARMs is positioned as a European-accessible supplier. The "UK" in the name refers to the company's primary operating base; researchers on the continent should check the supplier's shipping policy directly for their specific country, given the varied regulatory status of SARM and peptide research compounds across EU member states. As a European-based supplier, UK SARMs typically presents a more accessible regional supply chain than US-based vendors for researchers in the UK and parts of Europe. Confirm current shipping availability and any country-specific restrictions on the supplier site before ordering.
Q: How does UK SARMs' per-mg pricing on SARMs compare to US-based suppliers on Peptides.SO?
A: UK SARMs prices most SARM compounds at £40–£65 per standard capsule bottle (30-cap, 10mg/cap). Converted to per-mg terms, standard SARMs (LGD-4033, RAD-140, MK-2866, S-4, S23, YK-11) run £40–£55 for 300mg total at 10mg/cap, or approximately £0.13–£0.18/mg. US-based suppliers on Peptides.SO typically list SARMs in capsule format at similar or slightly higher USD pricing depending on format. For European researchers, UK SARMs eliminates currency conversion friction and potential import delays, which is a real logistics advantage even if per-mg cost is comparable.
Q: What does UK SARMs' GHK-Cu/BPC-157/TB-500 Blend ($24.99) contain and why is it priced so low?
A: At £24.99 (or the equivalent in GBP), this blend is priced well below what individual standalone vials of GHK-Cu, BPC-157, and TB-500 would cost from most suppliers. Blend products can achieve lower per-total-mg pricing when the individual compound quantities are small (e.g., 2–5mg each) and pre-formulated at a fixed ratio. Researchers considering this blend should note: (1) the specific mg quantities of each compound in the blend — critical for calculating dose-response equivalents; (2) the fixed ratio means you cannot adjust individual compound amounts without ordering standalone vials; and (3) the aggregate lot CoA may not break out per-compound purity. For researchers who need individual compound control, standalone vials are the appropriate choice; the blend suits researchers running fixed-protocol combined healing studies. See: BPC-157 | TB-500 | GHK-Cu compound page
Q: Is UK SARMs verified on Peptides.SO?
A: UK SARMs holds no verified badge on Peptides.SO, though the supplier does carry a 2.0/5.0 rating from 2 platform reviews (as of this review). The European regulatory framework for research compounds creates a distinct compliance environment from US suppliers — UK SARMs operates under UK/EU regulatory context rather than FDA jurisdiction. Researchers should request analytical testing documentation (HPLC purity, mass spectrometry, endotoxin) directly from the supplier, and assess documentation quality as a supplier-selection signal. Current listings are at the supplier profile.
Q: Does UK SARMs carry advanced GLP-1 compounds like Retatrutide or Tirzepatide?
A: Yes — the catalog includes Retatrutide ($109.99/vial) and Mazdutide 10mg ($89.99), which is notable for a European-based supplier. Retatrutide (LY3437943, Eli Lilly's GLP-1R/GIPR/GCGR triple agonist in Phase 3) and Mazdutide (GLP-1R/GCGR dual agonist in Asian clinical programs) are frontier metabolic research compounds that many US suppliers have added only recently. Their inclusion in UK SARMs' catalog suggests active tracking of emerging metabolic research compound demand. For comparison: Retatrutide is available from $5.70/mg on the platform's competitive end; UK SARMs' rate at £94.99 total (confirm current vial mg quantity for per-mg calculation) should be compared to the broader market. See: Retatrutide Research Profile
Q: What is RU58841, and is it appropriate for peptide research programs?
A: RU58841 is a non-steroidal selective androgen receptor antagonist investigated in hair follicle androgen-receptor biology research. Unlike SARMs (which are androgen receptor partial agonists for bone and muscle), RU58841 is a topical AR antagonist designed to prevent DHT from binding AR in hair follicle dermal papilla cells. Research applications include studying androgen-independent and androgen-dependent hair loss mechanisms, AR expression regulation in follicular tissue, and structure-activity relationships in non-steroidal AR antagonists. It is a distinct compound class from the peptides in this catalog. UK SARMs pricing RU58841 at £39.99 makes it one of the more accessible research-grade RU58841 sources for European researchers. See: Hair Loss Research Compounds for compound page reference.
> All compounds listed are for research use only. Not for human or animal consumption. Research Use Only.
---
UK SARMs 2026 Pricing Snapshot: Key Research Compounds
UK SARMs operates with European-standard pricing that reflects the import logistics and regulatory considerations of the UK market. The following table reflects verified September 2026 listings tracked on Peptides.SO:
| Compound | Format | Approx. Price (GBP/USD) | In Stock |
|---|---|---|---|
| YK-11 (10mg/mL, 30mL) | Liquid solution | £49.99 / ~$64 | ✓ |
| LGD-4033 (10mg/mL, 30mL) | Liquid solution | £54.99 / ~$70 | ✓ |
| RAD-140 (10mg/mL, 30mL) | Liquid solution | £54.99 / ~$70 | ✓ |
| Ostarine (MK-2866) | Liquid solution | £44.99 / ~$58 | ✓ |
| BPC-157 5mg | Lyophilized | £49.99 / ~$64 | ✓ |
| CJC-1295 No DAC 5mg | Lyophilized | £44.99 / ~$58 | ✓ |
| Ipamorelin 5mg | Lyophilized | £39.99 / ~$51 | ✓ |
| TB-500 5mg | Lyophilized | £44.99 / ~$58 | ✓ |
| Semaglutide | Lyophilized | Contact for pricing | ✓ |
| Tesamorelin 5mg | Lyophilized | £54.99 / ~$70 | ✓ |
Pricing shown at approximate 1.28 GBP/USD conversion rate; verify current pricing on the UK SARMs website.
---
SARMs Coverage: The Core Catalog
UK SARMs built its reputation around selective androgen receptor modulator research compounds, and this remains the catalog's foundation in 2026. The SARMs selection includes all major compounds currently under research:
Binding-selective SARMs (muscle/bone):
- •LGD-4033 (Ligandrol): One of the most-studied SARMs, with human pharmacokinetic data from Basaria et al. (2010) showing dose-dependent lean mass retention at low oral doses
- •RAD-140 (Testolone): Highly selective androgen receptor agonist; preclinical data shows neuroprotective properties alongside anabolic activity
- •MK-2866 (Ostarine): The most clinically tested SARM; Phase II data for muscle wasting available; also used in cachexia research models
- •S4 (Andarine): Partial androgen receptor agonist; used in comparative receptor selectivity research
Non-steroidal myostatin modulators:
- •YK-11: Myostatin inhibitor with partial androgen receptor agonist properties; structurally distinct from classic SARMs
- •MK-677 (Ibutamoren): Growth hormone secretagogue (not technically a SARM); orally active; used in sleep-phase GH pulse research
Tissue-selective agents:
- •GW-501516 (Cardarine): PPARδ agonist; not a SARM but commonly grouped; fat oxidation and endurance metabolism research
- •SR-9009 (Stenabolic): REV-ERB agonist; circadian rhythm and metabolic rate research
---
Peptide Coverage: The Expansion Category
UK SARMs has systematically expanded into research peptides, which now represent a significant portion of its 61-listing catalog. This reflects broader market trends as European researchers increasingly source peptides from SARM-specialized vendors who have established import and quality control infrastructure.
Growth Hormone Axis:
- •CJC-1295 No DAC (MOD-GRF 1-29): GHRH analog; pulsatile GH secretion research
- •Ipamorelin: Selective GHRP; used in sleep-phase pulsatile GH studies
- •Sermorelin: Shorter-half-life GHRH analog
- •Tesamorelin: FDA-approved GHRH analog; visceral adiposity reduction in HIV-lipodystrophy research
- •Hexarelin: Potent GHRP; also studied for cardiac-protective GH-independent effects
Healing and Recovery:
- •BPC-157: Gastric pentadecapeptide; joint and tendon repair research in animal models
- •TB-500 (Thymosin Beta-4): G-actin sequestrant; wound healing and anti-inflammatory research
- •GHK-Cu: Copper peptide; collagen synthesis and skin tissue repair
Metabolic:
- •Fragment 176-191: HGH lipolytic fragment; fat metabolism research without GH receptor activation
- •AOD-9604: Modified Fragment 176-191 analog; FDA Generally Recognized as Safe history
- •GLP-1 agonists: Semaglutide and Tirzepatide available for metabolic research
---
Regulatory Position: UK-Based Operations
UK SARMs operates under UK regulatory conditions that differ meaningfully from US-based suppliers:
Research compound legality in the UK:
- •SARMs are legal to buy, sell, and possess for research purposes in the UK as of 2026
- •They are not classified as controlled substances under the Misuse of Drugs Act 1971
- •Advertising restrictions prohibit claims related to human consumption or performance enhancement
Peptide import considerations:
- •Lyophilized research peptides imported into the UK for laboratory use do not require a license under most circumstances
- •Researchers importing from UK SARMs to EU countries should verify post-Brexit import documentation requirements
Product labeling:
- •UK SARMs follows "research use only" labeling standards consistent with UK scientific supply practices
---
Shipping and Fulfillment: European Strengths
For European-based researchers, UK SARMs offers advantages that US-based suppliers cannot match:
UK-to-EU shipping:
- •Significantly faster transit times for European research institutions compared to US-based alternatives
- •Reduced customs processing time relative to non-EU/non-UK origin shipments
- •Tracked shipping with established EU courier partnerships
UK domestic:
- •Next-day delivery options for UK-based orders
- •Standard tracked Royal Mail and courier service options
Payment methods:
- •Standard credit/debit card processing
- •Cryptocurrency payment accepted for privacy-conscious researchers
---
Frequently Asked Questions About UK SARMs
Q: Is UK SARMs suitable for non-European researchers?
A: UK SARMs primarily serves the UK and European research market. North American researchers should verify shipping availability, import declaration requirements, and potential customs duties before ordering. For most US-based researchers, a domestic US supplier will offer lower shipping costs and shorter transit times.
Q: How does UK SARMs' peptide pricing compare to US suppliers?
A: UK SARMs' peptide pricing, when converted to USD, typically sits 20-40% above equivalent US-based supplier pricing for standard compounds like BPC-157 and Ipamorelin. This premium reflects UK import, fulfillment, and operational costs. For UK/EU researchers, the total landed cost (including shipping and potential duties from US suppliers) often makes UK SARMs competitive or better.
Q: Does UK SARMs provide HPLC or mass spec testing certificates?
A: UK SARMs' product listings on Peptides.SO do not include upfront COA links. Researchers requiring purity certification should request documentation directly before purchase.
Q: What is UK SARMs' position on human consumption?
A: All products are labeled "for research purposes only" consistent with UK scientific supply regulations. UK SARMs explicitly disclaims human use in its product documentation.
Q: Does UK SARMs stock GLP-1 research compounds?
A: Yes — Semaglutide and Tirzepatide are listed in the catalog. Pricing and availability should be confirmed directly given the regulatory sensitivity of these compounds in the UK market.
Q: Are UK SARMs' SARMs in liquid or powder format?
A: Most SARM listings are in liquid solution format (typically 30mL at specified mg/mL concentrations), which is the standard form for UK SARM suppliers. Some compounds may be available in capsule or powder formats.
---
UK SARMs vs. European Competitors
| Feature | UK SARMs | Science.bio (EU) | PureRawz (US, ships EU) |
|---|---|---|---|
| UK/EU Shipping | ★★★★★ | ★★★★★ | ★★★☆☆ |
| SARM Depth | ★★★★★ | ★★★★☆ | ★★★★☆ |
| Peptide Coverage | ★★★★☆ | ★★★☆☆ | ★★★★★ |
| GLP-1 Compounds | ★★★☆☆ | ★★☆☆☆ | ★★★★☆ |
| Price (UK researchers) | ★★★★☆ | ★★★★☆ | ★★★☆☆ |
| COA Transparency | Moderate | Moderate | High |
---
Conclusion: UK SARMs in 2026
UK SARMs serves a specific and genuine need: European research institutions and UK-based researchers who require fast, compliant delivery of SARMs and research peptides without the extended transit times and customs uncertainty of US-origin shipments. The 61-listing catalog covers the SARMs research landscape comprehensively, and the peptide expansion category handles the most-researched healing, GH-axis, and metabolic compounds.
The main consideration for non-European researchers is whether the geographic premium is worth it versus ordering from a US supplier. For UK and EU researchers, UK SARMs represents a capable and established sourcing option.
Peptides.SO rating for UK SARMs: 4.0 / 5.0 — Strongly recommended for UK and European researchers; marginal for US-based research programs.
> All compounds available through UK SARMs are sold for in vitro laboratory research and scientific study purposes only. They are not intended for human consumption, clinical application, or veterinary use.